- EDITORIAL POLICY AND GENERAL INFORMATION
- ARTICLE TYPES
- PREPARATION OF MANUSCRIPT FOR SUBMISSION
- Cover letter
- Title page with author identifier
- Manuscript text without author identifier
- Information about scientific meetings
Journal of Advanced Research (JAR) provides publication of various original articles in the fields of basic sciences, applied sciences and technology, biomedical sciences, and related disciplines. JAR seeks to publish experimental and theoretical research results of outstanding significance in the form of original articles, short communications, reviews, case reports, or letters to the editor.
The JAR editors endorse the principles embodied in the revised Declaration of Helsinki (2008) (59th WMA General Assembly, Seoul, Republic of Korea, October 2008) and expect that all investigations involving humans would have been performed in accordance with these principles. For animal experimentation, it is expected that investigators would have observed the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences Adhoc Committee on Animal Research. All human and animal studies must have been approved by the investigator's Institutional review board.
Manuscripts are evaluated on the basis that they present new insights to the investigated topic and are likely to contribute to a research progress or change in clinical practice. It is understood that all authors listed on a manuscript have agreed to its submission. The signature of the corresponding author on the letter of submission signifies that these conditions have been fulfilled. Received manuscripts will be first examined by the JAR editorial office and manuscripts with insufficient priority for publication will be rejected without external evaluation. Manuscripts not prepared in the advised style will be sent back to authors for correction. The authors will be notified with the reference number once the manuscript has been assigned to an Editor. The registered manuscripts will be sent to independent experts for scientific evaluation. We encourage authors to suggest the names of four potential reviewers; however, the editors reserve the right of final selection. The evaluation process usually takes on average 1-3 months. Submitted papers will be accepted for publication after a positive opinion of the reviewers and editors. Authors should return the revised manuscript within 30 days from receiving an editorial decision.
Studies on patients or volunteers require Ethics Committee and/or Independent Review Board (IRB) approval, and, where relevant, the patients' written informed consent, which should be documented in the Methods section of the paper. If this study was not approved by the appropriate Ethics Committee or IRB, a statement as to why it was exempted should be included. The Editors reserve the right to refuse publications where the required ethical approval/patient consent is lacking.
Conflict of interests
A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict. This declaration (with the heading "Conflict of interests") should be fulfilled on the cover page at the time of submission.
Additional information regarding conflicts of interest can be found at http://www.wame.org/conflict-of-interest-editorial#ref1.
Materials taken from other sources must be accompanied by a written statement from both author and publisher giving permission to the journal for reproduction.
Upon acceptance of an article, authors will be asked to complete a 'Copyright Transfer Agreement'. Acceptance of the agreement will ensure the widest possible dissemination of information. Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of Cairo University is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations.
Every effort is made by the publisher and editorial board to see that no inaccurate or misleading data, opinion or statement appears in the Journal of Advanced Research. However, they wish to make it clear that the data and opinions appearing in the articles herein are the responsibility of the authors concerned. Accordingly, the publisher and the editorial board accept no liability whatsoever for the consequences of any such inaccurate or misleading data, opinion, or statement, whether intentional or not.
2. ARTICLES TYPES
- Original articles: Articles which represent in-depth research in various scientific disciplines.
- Case reports: A detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient. i.e clinically important information on common and rare conditions.
- Review articles: Should normally comprise less than 10,000 words; contain unstructured abstract and includes up-to-date references. Meta-analyses are considered as reviews. A special attention will be paid to a teaching value of a review paper.
- Mini reviews: These are reviews of important and recent topics that are presented in a concise and well-focused structure. The number of words is limited to 5,000 words.
- Short communications: Should be complete manuscripts of significant importance. However, their length and/or depth do not justify a full-length paper. The total number of figures and tables should not exceed 4. The number of words should be ≤ 2,500.
- Letter to the editor for comments on recently published articles.
- Special reports: Papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics.
Authors should submit their manuscripts to the editorial office as word files via the Elsevier Editorial System (EES) at http://ees.elsevier.com/jare.
The original manuscript should be formatted with double line spacing using the letter type Arial and/or Times New Roman (12 pt). The text should be in single-column format with justified margins. Do use bold face, italics, subscripts, and superscripts. To avoid unnecessary errors, the authors are strongly advised to use the "spell-check" and "grammar-check" functions of their word processing. All manuscript pages must be numbered at the bottom right corner of each page.
All submitted papers are subject to double blind peer-review and authors are urged to be brief; long papers with many tables and figures may require shortening if they are to be accepted for publication. While there is no length restriction for papers, authors are encouraged to limit the text to a maximum length of 4,000 words and references preferably not to be more than 35.
The manuscript should be compiled in the following order:
- Abstract, Key words
- Material and methods (Experimental or Methodology or Patients and methods)
- Discussion (Results and discussion can be combined in one section)
Manuscripts must be written in clear, concise, English language. Any author who is not fluent in idiomatic English is urged to gain assistance with manuscript preparation. Reviewers are not expected to correct grammatical errors and any deficiency in this area may detract from the scientific content of the paper.
The following items should be uploaded via Elsevier Electronic Submission (EES), http://ees.elsevier.com/jareCover letter
Please upload the filled-out standard cover letter, which can be downloaded here.
Title page with author identifier. This should include the following:
The title should be brief, concise, and descriptive. It should not contain any literature references or compound numbers or non standardized abbreviations.
- Authors and affiliations
Where possible, supply given names, middle initials, and family names for complete identification. Use superscript lowercase letters to indicate different affiliations, which should be as detailed as possible and must include the country name.
- The corresponding author should be indicated with an asterisk, and contact details (Tel., fax, and e-mail address) should be placed in a footnote.
- Short running title (running head) with 80 characters as maximum.
- Policy concerning add/removal of an author Requests to add or remove an author, or to rearrange the author names, must be sent to the Managing Editor at email@example.com from the corresponding author and must include: (a) the reason the name should be added or removed, and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Managing Editor to the corresponding author, who must follow the procedure as described above. Note that: (1) Managing Editor will inform the Editor in Chief of any such requests and (2) production of the accepted manuscript is suspended until authorship has been agreed.
- Title (as stated above in the title page)
Provide an unstructured abstract of not more than 250 words for indexing purpose. The abstract should briefly describe the purpose of the study, how the investigation was performed, the most important results and the principal conclusions that authors draw from the results, respectively. References should be avoided, but if essential, then cite the author(s) and year(s). Non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.
Authors are asked to provide (4 to 6) keywords, separated with semicolons. These keywords are used for indexing purposes.
The author(s) should strive to define the significance of the work and the justification for its publication. Any background discussion should be brief and restricted to pertinent material.
- Material and methods (Experimental or Methodology or Patients and methods)
Authors should be as concise as possible in experimental descriptions.
The Experimental section must contain all the information necessary to guarantee reproducibility. This section should be written in the past tense and include the weight, volume, etc., in parentheses after the names of the substances or solvents. General reaction conditions should be given only once.
The title of an experiment should include the chemical name and compound number of the product prepared; subsequently, this compound should be identified by its number.
All vendor details including company, city, and country should be mentioned.
Results should be clear and concise. Restrict tables and figures to the number needed to explain the argument of the paper and assess its support. Do not duplicate data in graphs and tables. The results should be presented in a logical sequence in the text, tables and illustrations. Emphasize only important observations.
- Guide lines for Statistical analysis and results format
1. For statistical analysis please write only the ones used in the MS in addition to hypothesized p-value or significant level (for example 0.05).
2. For each parameter or variable in Tables or graphs, please write :-
a-) Its nature (measurements, with its measurements units); counts (number of); percentage; ratio; scaled (on a scale from 1 to 10, or low to high orâ¦.. or else).
b-) Sample size used to compute its statistical measures and tests.
c-) The computed exact p-value for each test and the name of the test statistics , in addition to the value of the computed test Statistics for example (z â t- F- chi square -â¦â¦â¦).
- DiscussionThis should explore the significance of the results of the work, not repeat them. Include in the discussion the implications of the findings and their limitations, including inferences for future research. The discussion should confront the results of other investigations especially those quoted in the text.
The main conclusion(s) of the study should be presented in a short conclusions section that can stand alone. Should be linked with the goals of the study. State new hypotheses when warranted. Include recommendations when appropriate. Unqualified statements and conclusions not completely supported by the obtained data should be avoided.
Please acknowledge individual/company/institution who has contributed to the study by making substantial contributions to the design, acquisition of data, or analysis, and interpretation of data, or anyone who was involved in drafting the manuscript or revising it critically for important intellectual content. Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. List all contributors who do not meet the criteria for authorship, such as technical assistants, writing assistants or head of department who provided only general support. Financial and other material support should be disclosed and acknowledged.
Text: Indicate references by Arabic numerals in brackets, which run in order of appearance throughout the text (Vancouver style). For instance  or [7–10, 13,15]. The actual authors can be referred to, but the reference number(s) must always be given.
List: Number the references (e,g. 1.) in the list in the order in which they appear in the text. Journal names should be abbreviated according to Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html.
Examples of references (if 6 or fewer authors, list all; if 7 or more, list first 6 and add "et al."):
For journal articles
Abd El-Aty AM, Goudah A, Zhou HH. Pharmacokinetics of doxycycline after administration as a single intravenous bolus and intramuscular doses to non-lactating Egyptian goats. Pharmacol Res. 2004; 49(5): 487–91.
Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138:306–10.
Cozzi F, Morini F. Possible mechanisms of pacifier protection against SIDS [letter]. J Pediatr 2001; 138:783.
For Articles in Press (online)
Hellems MA, Gurka KK, Hayden GF. A review of The Journal of Pediatrics: The first 75 years. J Pediatr (2008). doi:10.1016/j.jpeds.2008.08.049.
Rosenstein BJ, Fosarelli PD. Pediatric pearls: the handbook of practical pediatrics. 3rd ed. St Louis: Mosby; 1997.
Virginia Law Foundation. The medical and legal implications of AIDS. Charlottesville (VA): The Foundation; 1987.
For chapters in books
Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill; 2001. p. 3421–52.
American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html -219.
For more samples please check:
Tables should be ≤ 6, and should include only essential data. They should be uploaded on separate sheets with their legends.
The number of illustrations should be ≤ 6 and appropriate for the data presented.
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with high resolution (300 dpi or more).
Illustrations should be referred to as Fig. 1, Figs. 2, 3–5, using Arabic numerals.
Each illustration should be accompanied by a legend clearly describing it.
Ensure that all tables, figures, and schemes are cited in the text in numerical order. The preferred position for chemical structures should be indicated.
All measurements and data should be given in SI units where possible, or in other internationally accepted units in parentheses throughout the text. Figures and Tables should use conventional units, with conversion factors given in legends or footnotes.
The preferred forms for some of the more commonly used abbreviations are mp, bp, °C, K, min, h, mL, &mgr;L, g, mg, &mgr;g, cm, mm, nm, mol, mmol, &mgr;mol, M, mM, &mgr;M, ppm, HPLC, TLC, GC, 1H NMR, GC-MS, HRMS, FABHRMS, UV, IR, EPR, ESR, DNase, ED50, ID50, IC50, LD50, im, ip, iv, mRNA, RNase, rRNA, tRNA, cpm, Ci, dpm, Vmax, Km, k, t1/2.
All non-standard abbreviations should be defined following the first use of the abbreviation.
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables, and figures. We will do our best to get your article published quickly and accurately. Therefore, it is important to ensure that all of your corrections are sent back in one communication within 72 h. proofreading is solely your responsibility. Note that the publisher may proceed with the publication of an article if no response is received.
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. The PDF file includes a cover sheet with the journal cover. Additional paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.